n CME : Your SA Journal of CPD - Human papillomavirus (HPV) vaccines : more about ... medical virology

Volume 29, Issue 5
  • ISSN : 0256-2170



The WHO advocates introduction of routine HPV vaccination as part of a national EPI programme provided HPV prevention is considered a health priority, and the programme is logistically feasible and financially sustainable. High vaccine costs are often cited as barriers to national public health usage. However, a recent study in Cape Town showed a cost benefit for routine HPV vaccination use. Cervical cancer screening programmes should continue, as genotypes not included in the vaccines may still cause malignant transformation.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error